Physician

Sarah Regan

According to 2025 Medicare claims, Sarah Regan (NPI: 1487017950) practices hematology/oncology in the Frederick-Gaithersburg-Bethesda, MD market, with the plurality of this provider's patient population coming from Montgomery, MD. This provider's primary affiliated billing organization is MARYLAND ONCOLOGY HEMATOLOGY, P.A. (NPI: 1821271032; TIN: 113652573) and primary practice location at 20850-6535.

Regan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 677 traditional Medicare patients, billed 112,136 HCPCS/CPT codes, and received $1,928,815 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 611 prescription claims across 139 beneficiaries totaling $1,628,550 in drug costs, led by Calquence (Acalabrutinib Maleate). 2023 DME data shows 43 claims. Open Payments data shows 24 records totaling $600. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $4,600 to $1,628,550. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.